Evidence map›Paper›PMID 9566900›Full record

ArticleMolecular and cellular biology1998

Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun.

A Zagariya, S Mungre, R Lovis, M Birrer, S Ness, B Thimmapaya, R Pope

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Transcriptional control of the TNF gene.Current directions in autoimmunity · 2010
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

A ZagariyaDepartment of Medicine, and Veterans Administration Lakeside Medical Center, Northwestern University Medical School, Chicago, Illinois 60611, USA.
S Mungre
R Lovis
M Birrer
S Ness
B Thimmapaya
R Pope
United States Department of Veterans Affairs · USNorthwestern University · USNational Institutes of Health · US

Funding

TRANSFORMING FUNCTIONS OF THE V-MYB ONCOGENE PRODUCTR01CA058443 · NCI · UNIVERSITY OF NEW MEXICO · PI NESS, SCOTT A. · 1995 to 2010
$2.6M
SUPERANTIGEN INTERACTIONS WITH MHC CLASS II ANTIGENSP60AR030692 · NIAMS · NORTHWESTERN UNIVERSITY · PI POPE, RICHARD M. · 1986 to 2001
$2.1M
TNFALPHA GENE IN RHEUMATOID ARTHRITISR01AR043642 · NIAMS · NORTHWESTERN UNIVERSITY · PI POPE, RICHARD M. · 1995 to 1998
–
NCI NIH HHS R01 CA058443NCI NIH HHS R01-CA-58443NIAMS NIH HHS P060-AR-30692NIAMS NIH HHS P60 AR030692NIAMS NIH HHS R01-AR-43642
6 · The paper itself

Abstract

Tumor necrosis factor alpha (TNF alpha) is a key regulatory cytokine whose expression is controlled by a complex set of stimuli in a variety of cell types. Previously, we found that the monocyte/macrophage-enriched nuclear transcription factor C/EBPbeta played an important role in the regulation of the TNF alpha gene in myelomonocytic cells. Abundant evidence suggests that other transcription factors participate as well. Here we have analyzed interactions between C/EBPbeta and c-Jun, a component of the ubiquitously expressed AP-1 complex. In phorbol myristate acetate (PMA)-treated Jurkat T cells, which did not possess endogenous C/EBPbeta, expression of c-Jun by itself had relatively little effect on TNF alpha promoter activity. However, the combination of C/EBPbeta and c-Jun was synergistic, resulting in greater than 130-fold activation. This effect required both the leucine zipper and DNA binding domains, but not the transactivation domain, of c-Jun, plus the AP-1 binding site centered 102/103 bp upstream of the transcription start site in the TNF alpha promoter. To determine if C/EBPbeta and c-Jun might cooperate to regulate the cellular TNF alpha gene in myelomonocytic cells, U937 cells that possess endogenous C/EBPbeta and were stably transfected with either wild-type c-Jun or the transactivation domain deletion mutant (TAM-67) were examined. U937 cells expressing ectopic wild-type c-Jun or TAM-67 secreted over threefold more TNF alpha than the control line in response to PMA plus lipopolysaccharide. Transient transfection of the U937 cells expressing TAM-67 suggested that TAM-67 binding to the -106/-99-bp AP-1 binding site cooperated with endogenous C/EBPbeta in the activation of the -120 TNF alpha promoter-reporter. DNA binding assays using oligonucleotides derived from the TNF alpha promoter suggested that C/EBPbeta and c-Jun interact in vitro and that the interaction may be DNA dependent. Our data demonstrate that the TNF alpha gene is regulated by the interaction of the ubiquitous AP-1 complex protein c-Jun and the monocyte/macrophage-enriched transcription factor C/EBPbeta and that this interaction contributes to the expression of the cellular TNF alpha gene in myelomonocytic cells. This interaction was unique in that it did not require the c-Jun transactivation domain, providing new insight into the cell-type-specific regulation of the TNF alpha gene.

Indexed as

Gene Expression RegulationCCAAT-Enhancer-Binding ProteinsDNA-Binding ProteinsGenes, ReporterHumansJurkat CellsNuclear ProteinsPromoter Regions, GeneticProtein BindingProto-Oncogene Proteins c-junT-LymphocytesTrans-ActivatorsTumor Necrosis Factor-alphaCCAAT-Enhancer-Binding ProteinsDNA-Binding ProteinsNuclear ProteinsProto-Oncogene Proteins c-junTrans-ActivatorsTumor Necrosis Factor-alpha

Identifiers

PMID9566900
PMCPMC110660
OpenAlexW2108404291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.